Home
  • 简体中文
  • Home
  • Health care professionals
  • Consumer
  • Partners
  • About BioGaia
  • Press
  • Investors
Health care professionals / Clinical Evidence / Other clinical research
Printer-friendly version Send to friend
  • Increase
  • Decrease
  • Normal

Current Size: 100%

Safety and colonisation

View related documentation:

Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life
Cow's milk allergic children can present sensitisation to probiotics
Colonization of the human gastrointestinal tract by the lactic acid bacteria Lactobacillus reuteri
Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnous GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread
Colonization and immunomodulation by L. reuteri in the human gastrointestinal tract
L. reuteri on H. pylori infections in humans
Characterization of L. reuteri DSM 17938.
Safety of L. reuteri in neonates
Safety and tolerance of L. reuteri in healthy adult male subjects.
Safety and tolerance of L. reuteri in HIV
Safety and tolerance of L. reuteri in early infancy
Safety of D(-)-lactic acid producing bacteria in the human infant.
Tolerance and fecal colonization with L. reuteri in children

 

  • Clinical Evidence
    • Acute diarrhoea
    • Antibiotic-associated diarrhoea (AAD)
    • Infant colic
    • General health
    • Helicobacter pylori
    • Oral health
    • Other clinical research
  • Scientific events
  • Basic research
  • Product quality and delivery systems
  • Reviews
  • BioGaia Probiotic products
CONTACT
ABOUT THE SITE I COOKIES
BUSINESS & PARTNER
Lotta Johansson
 
RESEARCH
Eamonn Connolly
 
PRESS
Peter Rothschild
 
INVESTORS
Margareta Hagman